Category Archives: Biotech

California Life Sciences to Partner with China

BIOCOM, a trade group representing Southern California’s life sciences industry, is ramping up partnership efforts in China to meet an emerging desire for novel drug therapies. While intellectual property (IP) protections and the Chinese government’s willingness to pay for expensive new products represent two large and lingering question marks, Joe Panetta, president and CEO at BIOCOM, [...]
Also posted in Emerging Markets, Global, IP, Market Access, R&D, leadership | Tagged , , , , | Leave a comment

First Chinese Product Development Partnership Targets Tuberculosis, Malaria, AIDS

A Chinese scientific foundation and a not-for-profit tuberculosis organization announced a partnership aimed at developing new medicines for underserved public health diseases. Billed as the first Chinese product development partnership (PDP), the Global Health R&D Center of China (GHRC) hopes to discover and develop new treatments for tuberculosis (TB) and other diseases by collaborating with pharmaceutical [...]
Also posted in Corporate Responsibility, Deals, Emerging Markets, Global, IP, Market Access, R&D, Technology, patient compliance | Tagged , | Leave a comment

California Biotech — Good Governance Tops Wish List

New industry survey data documents a fraying investment base marked by a distant and unresponsive FDA as well as an unprepared work force complacent about hungry foreign competition. California’s biotech industry has taken its annual pulse of business conditions — and while the prognosis is not for putting the state on the policy equivalent of life [...]
Also posted in FDA, R&D, Strategy, healthcare | Tagged , , , , , | Leave a comment

Fixing Biotech's Broken Business Model

Despite some notable successes, the global biotech industry has fallen short of expectations. Strategic collaborations have been on the increase, but there is now a need for more co-operation using new collaboration models, writes Jo Pisani. The current business model on which biotech has relied is flawed. Due to poor rates of return, investment has dried [...]
Also posted in Deals, Emerging Markets, Europe, Global, Guest Blog, R&D | Tagged , , , , , , , , | Leave a comment

Alliance Management is Being Neglected, Says Study

Survey finds disconnect between perceived importance of alliance management function at  C-level and actual commitment to it. The Rhythm of Business has released the results of a recent study titled The Practice of Alliance Management in the Biopharmaceutical Industry that examines the state of alliance management in pharmaceutical companies. The study, co-sponsored by the Biopharma Council [...]
Also posted in Strategy, leadership | Tagged , , | Leave a comment